South Korean Sleep-Tech Company LEESOL to Exhibit at 'Health Management EXPO 2026' from June 17-19
Key facts
- South Korean Sleep-Tech Company LEESOL to Exhibit at 'Health Management EXPO 2026' from June 17-19
- South Korean sleep-tech company LEESOL will exhibit at 'Health Management EXPO 2026' to be held at Tokyo Big Sight from June 17 to 19, 2026. The company will showcase its sleep care devices, 'sleepisol+' and 'blissol,' which utilize its proprietary 'CS-tACS' technology, proposing them as solutions for corporate health management and employee wellbeing in Japan.
- Source: PR Times
- Date: June 13, 2026
Direct answer
South Korean sleep-tech company LEESOL will exhibit at 'Health Management EXPO 2026' to be held at Tokyo Big Sight from June 17 to 19, 2026. The company will showcase its sleep care devices, 'sleepisol+' and 'blissol,' which utilize its proprietary 'CS-tACS' technology, proposing them as solutions for corporate health management and employee wellbeing in Japan.
- Citation
- South Korean Sleep-Tech Company LEESOL to Exhibit at 'Health Management EXPO 2026' from June 17-19 (June 13, 2026), PR Times
- Source
- PR Times
- Date
- June 13, 2026
South Korean sleep-tech company LEESOL will exhibit at 'Health Management EXPO 2026' to be held at Tokyo Big Sight from June 17 to 19, 2026. The company will showcase its sleep care devices, 'sleepisol+' and 'blissol,' which utilize its proprietary 'CS-tACS' technology, proposing them as solutions for corporate health management and employee wellbeing in Japan.
📋 Article Processing Timeline
- 📰 Published: June 13, 2026 at 00:00
- 🔍 Collected: June 12, 2026 at 15:21
- 🤖 AI Analyzed: June 12, 2026 at 16:21 (1h 0m after Collected)
LEESOL, a South Korean sleep-tech company recognized as a '2025 Baby Unicorn' by the South Korean government, will participate in 'Health Management EXPO 2026,' one of Japan's largest professional trade shows for corporate health and wellbeing, held at Tokyo Big Sight from June 17 (Wed) to 19 (Fri), 2026. LEESOL's headquarters are in Dong-gu, Busan, with R&D/Seoul offices in Gangnam-gu, Seoul. The company is led by co-CEOs Lee Seung-woo and Kwon Gu-seong.
At the event, LEESOL will showcase its 'sleepisol+/blissol' sleep care devices featuring its proprietary 'CS-tACS' technology. The company will present the relationship between sleep and corporate health, the potential for using these devices as employee benefits, and case studies of research and implementation in South Korea.
Addressing Management Issues for Japanese Companies
In recent years, decreased productivity and mental health issues caused by sleep deprivation have become major global social issues. Japan, in particular, faces chronic sleep deprivation, with average sleep duration among the lowest in the OECD. Sleep problems are not merely personal issues but critical factors affecting labor productivity, corporate competitiveness, and overall societal vitality.
Consequently, employee health is increasingly recognized as a vital resource for sustainable corporate growth. More companies are strengthening initiatives for sleep improvement and stress care as part of health management and wellbeing strategies. Leading firms are treating sleep as a part of human resource strategy, actively implementing measures to support employee condition.
LEESOL has addressed sleep challenges through its 'sleepisol' series, utilizing its patented 'CS-tACS' (Cranial Stimulation-transcranial Alternating Current Stimulation) technology. In South Korea, the company has expanded its business through multiple generations of product improvements and clinical research, now achieving annual sales of approximately 1 billion JPY. It has been designated a 'Baby Unicorn' startup by the South Korean government for its high growth potential.
Leveraging this experience and knowledge, LEESOL is now launching full-scale operations in Japan, focusing on corporate health management and employee benefits. This exhibition marks the first step, where attendees can experience the 'sleepisol+' device, designed for improved sleep quality, concentration, relaxation, and stress management.
Exhibition at 'Health Management EXPO 2026'
'Health Management EXPO 2026' gathers products and services related to corporate health management, employee benefits, and wellbeing. Exhibitors include health support services, health tech, mental health measures, and benefit solutions from Japan and abroad, attracting a wide range of visitors, from HR and general affairs managers to executive leadership.
LEESOL decided to exhibit to propose a new form of health support starting from sleep. The company aims to introduce 'sleepisol+/blissol' as a new approach to employee sleep issues and demonstrate its potential as a sleep solution contributing to health management and wellbeing.
Exhibited Product 1: 'sleepisol+'
sleepisol+ is a headband-type sleep care device equipped with the proprietary 'CS-tACS' technology.
- Product Name: sleepisol+
- Price: 29,900 JPY (including tax)
- Technology: Equipped with CS-tACS (Proprietary Brain Wave Synchronization Technology)
- Operation: Compatible with dedicated app
- Weight: Approx. 30g
- Charging: USB Type-C
- Modes: Sleep Mode, Concentration Mode, Stress Mode, Stability Mode
- Usage: Simply wear the headband device and select the mode based on the purpose.
Exhibited Product 2: 'blissol'
blissol is a headband-type sleep care device equipped with the proprietary 'CS-tACS' technology. It is designed for simplicity, specializing in a single function, eliminating the need for app connectivity or intensity adjustments.
- Product Name: blissol
- Price: 22,000 JPY (including tax)
- Technology: Equipped with CS-tACS (Proprietary Brain Wave Synchronization Technology)
At the event, LEESOL will showcase its 'sleepisol+/blissol' sleep care devices featuring its proprietary 'CS-tACS' technology. The company will present the relationship between sleep and corporate health, the potential for using these devices as employee benefits, and case studies of research and implementation in South Korea.
Addressing Management Issues for Japanese Companies
In recent years, decreased productivity and mental health issues caused by sleep deprivation have become major global social issues. Japan, in particular, faces chronic sleep deprivation, with average sleep duration among the lowest in the OECD. Sleep problems are not merely personal issues but critical factors affecting labor productivity, corporate competitiveness, and overall societal vitality.
Consequently, employee health is increasingly recognized as a vital resource for sustainable corporate growth. More companies are strengthening initiatives for sleep improvement and stress care as part of health management and wellbeing strategies. Leading firms are treating sleep as a part of human resource strategy, actively implementing measures to support employee condition.
LEESOL has addressed sleep challenges through its 'sleepisol' series, utilizing its patented 'CS-tACS' (Cranial Stimulation-transcranial Alternating Current Stimulation) technology. In South Korea, the company has expanded its business through multiple generations of product improvements and clinical research, now achieving annual sales of approximately 1 billion JPY. It has been designated a 'Baby Unicorn' startup by the South Korean government for its high growth potential.
Leveraging this experience and knowledge, LEESOL is now launching full-scale operations in Japan, focusing on corporate health management and employee benefits. This exhibition marks the first step, where attendees can experience the 'sleepisol+' device, designed for improved sleep quality, concentration, relaxation, and stress management.
Exhibition at 'Health Management EXPO 2026'
'Health Management EXPO 2026' gathers products and services related to corporate health management, employee benefits, and wellbeing. Exhibitors include health support services, health tech, mental health measures, and benefit solutions from Japan and abroad, attracting a wide range of visitors, from HR and general affairs managers to executive leadership.
LEESOL decided to exhibit to propose a new form of health support starting from sleep. The company aims to introduce 'sleepisol+/blissol' as a new approach to employee sleep issues and demonstrate its potential as a sleep solution contributing to health management and wellbeing.
Exhibited Product 1: 'sleepisol+'
sleepisol+ is a headband-type sleep care device equipped with the proprietary 'CS-tACS' technology.
- Product Name: sleepisol+
- Price: 29,900 JPY (including tax)
- Technology: Equipped with CS-tACS (Proprietary Brain Wave Synchronization Technology)
- Operation: Compatible with dedicated app
- Weight: Approx. 30g
- Charging: USB Type-C
- Modes: Sleep Mode, Concentration Mode, Stress Mode, Stability Mode
- Usage: Simply wear the headband device and select the mode based on the purpose.
Exhibited Product 2: 'blissol'
blissol is a headband-type sleep care device equipped with the proprietary 'CS-tACS' technology. It is designed for simplicity, specializing in a single function, eliminating the need for app connectivity or intensity adjustments.
- Product Name: blissol
- Price: 22,000 JPY (including tax)
- Technology: Equipped with CS-tACS (Proprietary Brain Wave Synchronization Technology)
FAQ
LEESOLの健康経営EXPO 2026での主な出展内容は？
独自技術「CS-tACS」を搭載したスリープケアデバイス「sleepisol＋」および「blissol」の体験展示、ならびに睡眠と健康経営の関係性や導入事例の紹介を行います。
「sleepisol＋」の特徴は？
独自技術「CS-tACS（独自脳波同調技術）」を搭載したヘッドバンド型デバイスで、睡眠、集中力、ストレス、安定の4モードを備え、専用アプリと連携可能です。
「blissol」はどのような製品か？
機能を1種類に特化させ、アプリ連携や強さ調整を不要にした、シンプルで使い勝手の良いヘッドバンド型スリープケアデバイスです。
LEESOLが韓国で評価されている理由は？
製品改良と臨床研究を重ね、韓国政府から将来性の高いスタートアップとして「ベビーユニコーン企業」に認定されており、年間約10億円の売上規模に成長しています。
健康経営EXPO 2026の開催日程と場所は？
2026年6月17日（水）から19日（金）まで、東京ビッグサイトで開催されます。